US growth delivers £13m turnover for Knutsford-based Crawford Healthcare

Wound care and dermatology firm Crawford Healthcare is celebrating after growing its half-year revenues by more than £2m.

The Knutsford-based business’ turnover leapt to £13m during the six months to September 30, a year-on-year rise of 19%.

Crawford Healthcare has attributed the growth to both its performance in the UK and overseas, in particular the US, where revenues from its North American subsidiary rose by 136% during the period.

The CEO of Crawford Healthcare, Richard Anderson, said: “As anticipated, we’ve enjoyed a really strong first six months for 2016/17, and we are well set to exceed expectations for the full year.

“The success of our wound care brands – now entirely owned and developed by Crawford – goes to show the quality of the Life Sciences industry in Cheshire and the North West.”

He added: “Like many others in the region, we’re enjoying tremendous success overseas and showing how our IP can lead international thinking and practice in healthcare.”

Crawford has achieved average annual sales growth of 41% over the last three years and today employs more than 130 people across its UK and international teams.

In July, a report found that one product developed by Crawford Healthcare alongside the University of Manchester could save the NHS as much as £125m a year.